Defence Therapeutics Inc (DTC.CX)
0.29
0.00 (0.00%)
CAD |
CNSX |
Nov 13, 16:00
Defence Therapeutics Enterprise Value : 21.82M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 21.82M |
| November 12, 2026 | 21.82M |
| November 11, 2026 | 23.33M |
| November 10, 2026 | 25.23M |
| November 09, 2026 | 24.85M |
| November 06, 2026 | 26.74M |
| November 05, 2026 | 26.36M |
| November 04, 2026 | 25.23M |
| November 03, 2026 | 25.61M |
| November 02, 2026 | 21.44M |
| October 30, 2026 | 26.36M |
| October 29, 2026 | 26.36M |
| October 28, 2026 | 26.36M |
| October 27, 2026 | 27.88M |
| October 26, 2026 | 31.67M |
| October 23, 2026 | 29.40M |
| October 22, 2026 | 29.02M |
| October 21, 2026 | 27.50M |
| October 20, 2026 | 27.50M |
| October 19, 2026 | 28.64M |
| October 16, 2026 | 25.61M |
| October 15, 2026 | 27.12M |
| October 14, 2026 | 25.99M |
| October 13, 2026 | 27.12M |
| October 09, 2026 | 30.15M |
| Date | Value |
|---|---|
| October 08, 2026 | 28.64M |
| October 07, 2026 | 30.15M |
| October 06, 2026 | 29.40M |
| October 05, 2026 | 32.05M |
| October 02, 2026 | 29.40M |
| October 01, 2026 | 30.15M |
| September 30, 2026 | 30.15M |
| September 29, 2026 | 29.78M |
| September 28, 2026 | 30.15M |
| September 25, 2026 | 32.81M |
| September 24, 2026 | 35.46M |
| September 23, 2026 | 37.73M |
| September 22, 2026 | 34.70M |
| September 21, 2026 | 34.32M |
| September 18, 2026 | 34.32M |
| September 17, 2026 | 36.97M |
| September 16, 2026 | 37.73M |
| September 15, 2026 | 37.73M |
| September 14, 2026 | 36.97M |
| September 11, 2026 | 36.22M |
| September 10, 2026 | 36.97M |
| September 09, 2026 | 36.97M |
| September 08, 2026 | 36.97M |
| September 04, 2026 | 38.49M |
| September 03, 2026 | 37.73M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Spectral Medical, Inc. | 321.20M |
| Resverlogix Corp. | 135.88M |
| Theratechnologies, Inc. | -- |
| COSCIENS Biopharma, Inc. | 15.23M |
| Restart Life Sciences Corp. | 3.639M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.499M |
| Total Expenses (Quarterly) | 1.499M |
| EPS Diluted (Quarterly) | -0.0198 |
| Earnings Yield | -38.03% |
| Normalized Earnings Yield | -32.38 |